This proposal requests continued support for the Medical Scientist Training Program (MSTP) at Vanderbilt University School of Medicine. The primary goal of the Vanderbilt MSTP is to identify, mentor, and foster the careers of future leaders in academic medicine who are dedicated to improving human health through discovery. The program is based on rigorous training in clinical medicine and scientific inquiry. Successful completion of the MSTP leads to both M.D. and Ph.D. degrees. Core elements of the program developed specifically for dual-degree students include a foundational course in research, literature-based seminar series, clinical preceptorship program, data club, leadership workshop, career development workshop, physician-scientist speaker series, and an annual retreat. Formal instruction in the responsible conduct of research is provided throughout the curriculum. MSTP students are assigned to one of four innovative advising colleges that provide a framework for academic counseling by faculty and peers. Current students play key roles in new student recruitment, program administration, and curriculum development. Seventy-two percent of our graduates with established careers hold academic or private-sector research positions, including two deans, four department chairs, and 24 full professors. More recent graduates have been placed in superb residencies and fellowships. The 92 current trainees come from 57 colleges and universities distributed across North America. The nationwide applicant pool results from concerted recruiting efforts, including those focused on the recruitment of students from groups underrepresented in medicine. In the current year, 380 applications have been received, from which 12 students will be selected to enter the incoming class. The proposed goal is to increase the size of the program to a steady state of 112 students over the next five years. Extramural research funding at Vanderbilt has increased from $389 million to $444 million since 2008. Research opportunities for MSTP trainees include established strengths in biomedical informatics, cancer biology, cell biology, clinical pharmacology, diabetes, neurosciences, toxicology, and vaccine science as well as new areas of emphasis in chemical and physical biology, drug discovery, genetics, imaging sciences, microbial pathogenesis, pharmacogenomics, and structural biology. As such, the educational environment for physician- scientists at Vanderbilt is outstanding. The proposal requests an increase in funded positions to 24 for the five- year project period. Ongoing support for the Vanderbilt MSTP is justified based on the strength of the applicant pool, numerous opportunities for physician-scientist training, an institutional commitment to the education of leaders in biomedical research, and success of our graduates in academic medicine.

Public Health Relevance

The Vanderbilt Medical Scientist Training Program supports the training of physician-scientists who seek to improve human health through basic, translational, or clinical research. The broad public health significance of this program will be realized through the academic and scholarly accomplishments of the trainees, with connections to both the direct treatment of patients in the clinical setting and the discovery of basic disease mechanisms and new therapeutic agents.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Institutional National Research Service Award (T32)
Project #
5T32GM007347-38
Application #
9102228
Study Section
Training and Workforce Development Subcommittee - D (TWD)
Program Officer
Preusch, Peter
Project Start
1977-07-01
Project End
2019-06-30
Budget Start
2016-07-01
Budget End
2017-06-30
Support Year
38
Fiscal Year
2016
Total Cost
Indirect Cost
Name
Vanderbilt University Medical Center
Department
Pediatrics
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37240
Stothers, C L; Luan, L; Fensterheim, B A et al. (2018) Hypoxia-inducible factor-1? regulation of myeloid cells. J Mol Med (Berl) 96:1293-1306
Watchmaker, Jennifer M; Juttukonda, Meher R; Davis, Larry T et al. (2018) Hemodynamic mechanisms underlying elevated oxygen extraction fraction (OEF) in moyamoya and sickle cell anemia patients. J Cereb Blood Flow Metab 38:1618-1630
McKenna, Matthew T; Weis, Jared A; Brock, Amy et al. (2018) Precision Medicine with Imprecise Therapy: Computational Modeling for Chemotherapy in Breast Cancer. Transl Oncol 11:732-742
Hartmann, Katherine E; Sundermann, Alexandra C; Helton, Rebecca et al. (2018) The Scope of Extraprofessional Caregiving Challenges Among Early Career Faculty: Findings From a University Medical Center. Acad Med 93:1707-1712
Bloodworth, Melissa H; Rusznak, Mark; Pfister, Connor C et al. (2018) Glucagon-like peptide 1 receptor signaling attenuates respiratory syncytial virus-induced type 2 responses and immunopathology. J Allergy Clin Immunol 142:683-687.e12
Choksi, Yash A; Reddy, Vishruth K; Singh, Kshipra et al. (2018) BVES is required for maintenance of colonic epithelial integrity in experimental colitis by modifying intestinal permeability. Mucosal Immunol 11:1363-1374
Knowlton, Jonathan J; Fernández de Castro, Isabel; Ashbrook, Alison W et al. (2018) The TRiC chaperonin controls reovirus replication through outer-capsid folding. Nat Microbiol 3:481-493
Palmisano, Brian T; Zhu, Lin; Eckel, Robert H et al. (2018) Sex differences in lipid and lipoprotein metabolism. Mol Metab 15:45-55
Zhou, Weisong; Zhang, Jian; Toki, Shinji et al. (2018) The PGI2 Analog Cicaprost Inhibits IL-33-Induced Th2 Responses, IL-2 Production, and CD25 Expression in Mouse CD4+ T Cells. J Immunol 201:1936-1945
Brissova, Marcela; Haliyur, Rachana; Saunders, Diane et al. (2018) ? Cell Function and Gene Expression Are Compromised in Type 1 Diabetes. Cell Rep 22:2667-2676

Showing the most recent 10 out of 536 publications